Shareholders' equity · 2021–2025
Bioventus shareholders' equity
$184M+24.4% · FY2025
Bioventus (BVS) reported $184M in shareholders' equity for fiscal 2025, +24.4% year on year.
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2021–2025 compound annual growth −20.4%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Bioventus shareholders' equity |url=https://companiesranked.com/en/company/bioventus/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Bioventus shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/bioventus/shareholders-equityBibTeX
@misc{companiesranked-en-company-bioventus-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Bioventus shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/bioventus/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001665988-26-000042 · August 5, 2026
{{cite web |title=Bioventus shareholders' equity — 10-Q (0001665988-26-000042) |url=https://www.sec.gov/Archives/edgar/data/1665988/000166598826000042/bvs-20260627.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.